Comparison of complement dependent lytic, hemagglutination inhibition and microneutralization antibody responses in influenza vaccinated individuals

References

• de Jong JC, Palache AM, Beyer WE, Rimmelzwaan GF, Boon AC, Osterhaus AD. Haemagglutination-inhibiting antibody to influenza virus. Dev Biol (Basel) 2003; 115:63 - 73; PMID: 15088777
   PubMedGoogle Scholar
• Natsume A, Niwa R, Satoh M. Improving effector functions of antibodies for cancer treatment: Enhancing ADCC and CDC. Drug Des Devel Ther 2009; 3:7 - 16; PMID: 19920917
   PubMed Web of Science ®Google Scholar
• Verbonitz MW, Ennis FA, Hicks JT, Albrecht P. Hemagglutinin-specific complement-dependent cytolytic antibody response to influenza infection. J Exp Med 1978; 147:265 - 70; http://dx.doi.org/10.1084/jem.147.1.265; PMID: 627837
   PubMed Web of Science ®Google Scholar
• Co MD, Orphin L, Cruz J, Pazoles P, Rothman AL, Ennis FA, et al. Discordance between antibody and T cell responses in recipients of trivalent inactivated influenza vaccine. Vaccine 2008; 26:1990 - 8; http://dx.doi.org/10.1016/j.vaccine.2008.02.024; PMID: 18339461
   PubMed Web of Science ®Google Scholar
• Szretter KJ, Balish AL, Katz JM. Influenza: propagation, quantification, and storage. Curr Protoc Microbiol 2006; Chapter 15:Unit 15G 1.
   Google Scholar
• Quinnan GV, Ennis FA, Tuazon CU, Wells MA, Butchko GM, Armstrong R, et al. Cytotoxic lymphocytes and antibody-dependent complement-mediated cytotoxicity induced by administration of influenza vaccine. Infect Immun 1980; 30:362 - 9; PMID: 7439982
   PubMed Web of Science ®Google Scholar
• Reading PC, Hartley CA, Ezekowitz RA, Anders EM. A serum mannose-binding lectin mediates complement-dependent lysis of influenza virus-infected cells. Biochem Biophys Res Commun 1995; 217:1128 - 36; http://dx.doi.org/10.1006/bbrc.1995.2886; PMID: 8554567
   PubMed Web of Science ®Google Scholar
• Papenburg J, Baz M, Hamelin MÈ, Rhéaume C, Carbonneau J, Ouakki M, et al. Evaluation of serological diagnostic methods for the 2009 pandemic influenza A (H1N1) virus. Clin Vaccine Immunol 2011; 18:520 - 2; http://dx.doi.org/10.1128/CVI.00449-10; PMID: 21228145
   PubMed Web of Science ®Google Scholar
• Huber M, Trkola A. Humoral immunity to HIV-1: neutralization and beyond. J Intern Med 2007; 262:5 - 25; http://dx.doi.org/10.1111/j.1365-2796.2007.01819.x; PMID: 17598812
   PubMed Web of Science ®Google Scholar
• Hicks JT, Ennis FA, Kim E, Verbonitz M. The importance of an intact complement pathway in recovery from a primary viral infection: influenza in decomplemented and in C5-deficient mice. J Immunol 1978; 121:1437 - 45; PMID: 701803
   PubMed Web of Science ®Google Scholar
• Hicks JT, Klutch MJ, Albrecht P, Frank MM. Analysis of complement-dependent antibody-mediated lysis of target cells acutely infected with measles. J Immunol 1976; 117:208 - 15; PMID: 819582
   PubMed Web of Science ®Google Scholar
• Qu Z, Liang X, Liu Y, Du J, Liu S, Sun W. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59. Mol Immunol 2009; 47:283 - 9; http://dx.doi.org/10.1016/j.molimm.2009.09.022; PMID: 19804910
   PubMed Web of Science ®Google Scholar
• Sissons JG, Cooper NR, Oldstone MB. Alternative complement pathway-mediated lysis of measles virus infected cells: induction by IgG antibody bound to individual viral glycoproteins and comparative efficacy of F(ab’)2 and Fab’ fragments. J Immunol 1979; 123:2144 - 9; PMID: 489977
   PubMed Web of Science ®Google Scholar
• Patrick Sissons JG, Schreiber RD, Perrin LH, Cooper NR, Müller-Eberhard HJ, Oldstone MB. Lysis of measles virus-infected cells by the purified cytolytic alternative complement pathway and antibody. J Exp Med 1979; 150:445 - 54; http://dx.doi.org/10.1084/jem.150.3.445; PMID: 479760
   PubMed Web of Science ®Google Scholar
• Terajima M, Cruz J, Co MD, Lee JH, Kaur K, Wrammert J, et al. Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies. J Virol 2011; 85:13463 - 7; http://dx.doi.org/10.1128/JVI.05193-11; PMID: 21994454
   PubMed Web of Science ®Google Scholar
• Mozdzanowska K, Feng J, Eid M, Zharikova D, Gerhard W. Enhancement of neutralizing activity of influenza virus-specific antibodies by serum components. Virology 2006; 352:418 - 26; http://dx.doi.org/10.1016/j.virol.2006.05.008; PMID: 16777168
   PubMed Web of Science ®Google Scholar
• Banzhoff A, Pellegrini M, Del Giudice G, Fragapane E, Groth N, Podda A. MF59-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis. Influenza Other Respir Viruses 2008; 2:243 - 9; http://dx.doi.org/10.1111/j.1750-2659.2008.00059.x; PMID: 19453401
   PubMed Web of Science ®Google Scholar
• Palese P. Influenza: old and new threats. Nat Med 2004; 10:Suppl S82 - 7; http://dx.doi.org/10.1038/nm1141; PMID: 15577936
   PubMed Web of Science ®Google Scholar
• Wrammert J, Koutsonanos D, Li GM, Edupuganti S, Sui J, Morrissey M, et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 2011; 208:181 - 93; http://dx.doi.org/10.1084/jem.20101352; PMID: 21220454
   PubMed Web of Science ®Google Scholar
• Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667 - 71; http://dx.doi.org/10.1038/nature06890; PMID: 18449194
   PubMed Web of Science ®Google Scholar
• Yewdell JW, Bennink JR, Smith GL, Moss B. Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1985; 82:1785 - 9; http://dx.doi.org/10.1073/pnas.82.6.1785; PMID: 3872457
   PubMed Web of Science ®Google Scholar
• Grandea AG 3rd, Olsen OA, Cox TC, Renshaw M, Hammond PW, Chan-Hui PY, et al. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc Natl Acad Sci USA 2010; 107:12658 - 63; http://dx.doi.org/10.1073/pnas.0911806107; PMID: 20615945
   PubMed Web of Science ®Google Scholar
• Palese P, Shaw M. Orthomyxoviridae: The Viruses and Their Replication. In: David M. Knipe PMH, ed. Fields' virology Philadelphia: Lippincott Williams & Wilkins 2007:1655,722-723.
   Google Scholar
• Gardner EM, Bernstein ED, Dran S, Munk G, Gross P, Abrutyn E, et al. Characterization of antibody responses to annual influenza vaccination over four years in a healthy elderly population. Vaccine 2001; 19:4610 - 7; http://dx.doi.org/10.1016/S0264-410X(01)00246-8; PMID: 11535308
   PubMed Web of Science ®Google Scholar
• Hirota Y, Kaji M, Ide S, Goto S, Oka T. The hemagglutination inhibition antibody responses to an inactivated influenza vaccine among healthy adults: with special reference to the prevaccination antibody and its interaction with age. Vaccine 1996; 14:1597 - 602; http://dx.doi.org/10.1016/S0264-410X(96)00153-3; PMID: 9032887
   PubMed Web of Science ®Google Scholar
• Beyer WE, Palache AM, Lüchters G, Nauta J, Osterhaus AD. Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination?. Virus Res 2004; 103:125 - 32; http://dx.doi.org/10.1016/j.virusres.2004.02.024; PMID: 15163500
   PubMed Web of Science ®Google Scholar